期刊文献+

结直肠癌肝转移多学科综合治疗模式建立和推广 被引量:5

The setting of multidisciplinary team for colorectal liver metastasis
原文传递
导出
摘要 结直肠癌肝转移是结直肠癌病人最主要的死亡原因。通过多学科综合治疗团队(MDT)开展积极的综合治疗有望提高结直肠癌肝转移灶的手术切除率和和5年存活率。良好的MDT需要医疗机构管理部门和临床医生的共同努力。目前在国内的一些医疗机构中已经建立了较为规范完善的结直肠癌专病MDT,但进一步推广、普及还任重道远。 Liver metastasis is the major death cause of colorectal cancer. The resection and survival rate of liver metastasis from coloreetal cancer could be dramatically improved through multidisciplinary team (MDT). The effective MDT could only achieved by joint efforts from administration and physicians in a hospital. Some standard MDTs for colorectal cancer have been established in some hospitals of China, which still need to be developed and popularized.
作者 张苏展
出处 《中国实用外科杂志》 CSCD 北大核心 2013年第8期625-627,共3页 Chinese Journal of Practical Surgery
关键词 结直肠癌 肝转移 多学科综合治疗团队 colorectal cancer liver metastases multidisci-plinary team
  • 相关文献

参考文献4

  • 1Adam R, De Gramont A, Figueras J, et al. The oncosurgery ap- proach to managing liver metastases from colorectal cancer:'A multidisciplinary international consensus [J]. Oncologist, 2012, 17(10)1225-1239.
  • 2Schmo11 HJ, Van Cutsem E, Stein A, et al. ESMO Consensus Guidelines for management of patients with colon and rectal can- cer. A personalized approach to clinical decision making [J]. Ann Oncol, 2012,23 (10) : 2479-2516.
  • 3NCCN Clincal Practice Guidelines in Oncology. Colon Cancer. 2013 V-3 [ J/OL ] .www.nccn.org/clinical.asp.
  • 4结直肠癌诊疗规范(2010年版)[J].中华胃肠外科杂志,2010,13(11):865-875. 被引量:163

共引文献162

同被引文献63

  • 1Kathryn Field,Lara Lipton.Metastatic colorectal cancer-past,progress and future[J].World Journal of Gastroenterology,2007,13(28):3806-3815. 被引量:8
  • 2Adam R, De Gramont A, Figueras J, et al.The oneosurgery ap- proach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus [ J ]. Oncologist, 2012, 17(10):1225-1239.
  • 3Xu J, Qin X, Wang J, et al.Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer[J].J Cancer Res Clin Oncol,2011,137(9): 1379-1396.
  • 4Schmoll HJ, Van Cutsem E, Stein A, et al.ESMO Consensus Guidelines for management of patients with colon and rectal can- cer. a personalized approach to clinical decision making[J].Ann Oncol, 2012,23(10) : 2479-2516.
  • 5Zelck L, Bugat R, Cherqui D, et al.Muhimodal therapy with in- travenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in nonresect- able hepatic metastases from colorectal cancer [J].Ann Oncol, 2003,14(10) : 1537-1542.
  • 6Suzuki C, Blomqvist L, Sundin A, et al.The initial change in tu- mor size predicts response and survival in patients with metastat- ic colorectal cancer treated with combination chemotherapy [J]. Ann Oncol, 2012,23(4) :948-954.
  • 7Silvestri A, Pin E, Huijbers A, et al.lndividualized therapy for metastatic colorectal cancer [J].J Intern Med, 2013, 274(1): 1-24.
  • 8Edwards MS, Chadda SD, Zhao Z, et al.A systematic review of treatment guidelines for metastatic eoloreetal cancer[J].Colorec- tal Dis, 2012,14(2): 31-47.
  • 9Augestad KM, Lindsetmo RO, Stulberg J, et al.International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams [J].World J Surg, 2010,34(11) : 2689-2700.
  • 10Burton S, Brown G, Danicls IR, et aI.MRI directed multidisci- plinary team preoperative treatment strategy : the way to elimi- nate positive circumferential margins [J].Br J Cancer, 2006,94 (3) : 351-357.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部